Javascript must be enabled to continue!
A novel diagnostic algorithm for heparin‐induced thrombocytopenia
View through CrossRef
AbstractIntroductionWhile diagnostic algorithm using PF4‐heparin enzyme‐linked immunosorbent assay (ELISA) optical density (OD), and heparin neutralization assay (HNA), or 4T score have been proposed to replace serotonin‐release assay (SRA) for heparin‐induced thrombocytopenia (HIT), their performance against SRA is unclear. In this study, we proposed and validated the performance of a new algorithm combining PF4‐heparin ELISA optical density (OD), HNA and 4T score against SRA for HIT diagnosis.MethodsHeparin neutralization assays were performed on specimens submitted for HIT testing with positive PF4‐heparin ELISA from December 2015 to September 2017, which were separated into a “training” and a “validation” data set. 4T scores were calculated for ELISA positive cases.ResultsA total of 123 consecutive unique patient samples had positive PF4‐heparin ELISA with also HNA data, SRA data, and 4T scores available. Compared to SRA, a “laboratory criteria” (ELISA OD ≥ 1.4 and HNA ≥ 70%) had a sensitivity of 88% (14/16) and specificity of 91% (42/46), and a “combined criteria” (4T score = 8, or 4T score = 6 or 7 and ELISA OD ≥ 1.0, or 4T score = 4 or 5 and ELISA OD ≥ 2.0) had a sensitivity of 75% (12/16) and specificity of 98% (45/46) in the training data set. Laboratory and combined criteria had 90% (56/62) concordance rate. Importantly, for these concordant cases, the diagnostic specificity is 100% (46/46). Based on the data, a novel diagnostic algorithm combining these 2 criteria was proposed and validated prospectively.ConclusionA novel algorithm has high diagnostic accuracy and potentially could eliminate the need for SRA testing in at least 90% patients with suspected HIT.
Title: A novel diagnostic algorithm for heparin‐induced thrombocytopenia
Description:
AbstractIntroductionWhile diagnostic algorithm using PF4‐heparin enzyme‐linked immunosorbent assay (ELISA) optical density (OD), and heparin neutralization assay (HNA), or 4T score have been proposed to replace serotonin‐release assay (SRA) for heparin‐induced thrombocytopenia (HIT), their performance against SRA is unclear.
In this study, we proposed and validated the performance of a new algorithm combining PF4‐heparin ELISA optical density (OD), HNA and 4T score against SRA for HIT diagnosis.
MethodsHeparin neutralization assays were performed on specimens submitted for HIT testing with positive PF4‐heparin ELISA from December 2015 to September 2017, which were separated into a “training” and a “validation” data set.
4T scores were calculated for ELISA positive cases.
ResultsA total of 123 consecutive unique patient samples had positive PF4‐heparin ELISA with also HNA data, SRA data, and 4T scores available.
Compared to SRA, a “laboratory criteria” (ELISA OD ≥ 1.
4 and HNA ≥ 70%) had a sensitivity of 88% (14/16) and specificity of 91% (42/46), and a “combined criteria” (4T score = 8, or 4T score = 6 or 7 and ELISA OD ≥ 1.
0, or 4T score = 4 or 5 and ELISA OD ≥ 2.
0) had a sensitivity of 75% (12/16) and specificity of 98% (45/46) in the training data set.
Laboratory and combined criteria had 90% (56/62) concordance rate.
Importantly, for these concordant cases, the diagnostic specificity is 100% (46/46).
Based on the data, a novel diagnostic algorithm combining these 2 criteria was proposed and validated prospectively.
ConclusionA novel algorithm has high diagnostic accuracy and potentially could eliminate the need for SRA testing in at least 90% patients with suspected HIT.
Related Results
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Abstract
Introduction
Among the most frequently used anticoagulants in hematological testing are tetra-acetic acid (EDTA), sodium citrate, and sodium heparin. However, there is a n...
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Abstract
Introduction
Thromobocytopenia is a well-recognized complication of heparin with risk of venous or arterial thrombosis. Heparin induced throm...
Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes
Novel ELISA-Based Assay for Detection of Complement Activation By PF4/Heparin Complexes
Abstract
The immune response to platelet factor 4 (PF4)/heparin complexes is a frequent iatrogenic complication of heparin therapy associated with development of hep...
HEPARIN BINDING TO HUMAN MONOCYTES: MODULATION BY HISTIDINE-RICH GLYCOPROTEIN
HEPARIN BINDING TO HUMAN MONOCYTES: MODULATION BY HISTIDINE-RICH GLYCOPROTEIN
Heparin and its related glycosaminoglycans interact with a variety of cell types and, irrespective of their anticoagulant activities, have a complex and biologically important infl...
Clinical and economic burden of heparin-induced thrombocytopenia in hospitalized patients undergoing percutaneous peripheral arterial interventions
Clinical and economic burden of heparin-induced thrombocytopenia in hospitalized patients undergoing percutaneous peripheral arterial interventions
Background
Percutaneous peripheral arterial intervention (PPAI) patients are at a high risk of developing heparin-induced thrombocytopenia due to the need for r...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract
Introduction
Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
Heparin binds to smooth muscle cells and endothelial cells. It inhibits the proliferation of the smooth muscle cells and modulates the growth of endothelial cells. Fibroblasts whic...
Thrombocytopenia in post Covid era: puzzle in the diagnosis.
Thrombocytopenia in post Covid era: puzzle in the diagnosis.
World Health Organization declared the outbreak of coronavirus disease 2019 (COVID-19) a pandemic on March 11, 2020, researchers and clinicians have worked diligently to learn ever...

